JJDC Hired Asha Nayak MD PhD  
Vice President Investor Consumer Health
Asha Nayak MD PhD
Asha joins Johnson & Johnson Development Corporation with over 20 years of experience developing medical technologies. Throughout her career, Asha has focused on game-changing breakthroughs that move the needle for large numbers of patients in life-changing ways. As a practicing physician, she is especially interested in technologies that cure, prevent, and deliver therapies with precision. In addition to her work in development, Asha brings 10+ years of corporate and venture investment experience to JJDC. 
Prior to her start at JJDC Asha served as a board of director at Sage Therapeutics, HD Medical, and Stanford University. She has assisted numerous startup companies in the Silicon Valley while maintaining her position as an ER Physician at Stanford VA Hospital since 2001.
Welcome to The JJDC team Asha!
Johnson & Johnson Innovation – JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson. JJDC pursues opportunities to solve critical healthcare needs. Their portfolio companies benefit from the full global capabilities of Johnson & Johnson as they collaborate to drive innovation. JJDC finds transformative ideas and helps them mature into real solutions for today’s patients. Guided by a clear, consistent investment strategy aligned with scientific goals, JJDC works hand-in-hand with partners to navigate the path to creating breakthrough health innovations. They invest across sectors-pharmaceuticals, medical devices, and consumer healthcare-and at all stages, from seed-level startups to Series B and beyond.  
Learn more at www.jnjinnovation.com/jjdc